Melissa B Epperly insider trades

Open-market stock purchases and sales by Melissa B Epperly, Director at Roivant Sciences Ltd, from SEC Form 4 filings since Apr 7, 2020.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -92%.

Recent trades

DateStockTradeValue
Oct 1, 2026ROIV Roivant Sciences LtdSold$608K
Oct 1, 2026ROIV Roivant Sciences LtdSold$32.9K
Oct 1, 2026ROIV Roivant Sciences LtdBought (not open market)—
Sep 16, 2026ROIV Roivant Sciences LtdBought (not open market)—
Sep 16, 2026ROIV Roivant Sciences LtdBought (not open market)—
Sep 15, 2026ROIV Roivant Sciences LtdSold$172K
Sep 15, 2026ROIV Roivant Sciences LtdSold$24.2K
Sep 10, 2026ROIV Roivant Sciences LtdSold (not open market)$89.2K
Jul 17, 2026ROIV Roivant Sciences LtdBought (not open market)—
Jun 29, 2026ROIV Roivant Sciences LtdBought (not open market)$79.2K
Jun 29, 2026ROIV Roivant Sciences LtdSold$515K
Jun 29, 2026ROIV Roivant Sciences LtdSold$95.4K
Jun 29, 2026ROIV Roivant Sciences LtdBought (not open market)—
Jun 18, 2026NAUT Nautilus Biotechnology, IncBought (not open market)—
Apr 17, 2026ROIV Roivant Sciences LtdBought (not open market)—
Mar 16, 2026ROIV Roivant Sciences LtdSold$1.2M
Jan 20, 2026ROIV Roivant Sciences LtdBought (not open market)—
Jan 20, 2026ROIV Roivant Sciences LtdSold (not open market)$1.2K

Companies traded

  • ROIV Roivant Sciences Ltd: 7 sales, last Oct 1, 2026
  • NAUT Nautilus Biotechnology, Inc: other filings, last Jun 18, 2026
  • KNTE Kinnate Biopharma Inc: other filings, last Apr 3, 2024
  • ZNTL Zentalis Pharmaceuticals, Inc: 3 buys, 46 sales, last Feb 12, 2024

Get free alerts when Melissa B Epperly files a new trade →